Chronic obstructive pulmonary disease, commonly referred to as COPD, is typically comprised of three related conditions: chronic bronchitis, chronic asthma, and emphysema. In each condition, there is chronic obstruction of air flow through the airways and out of the lungs; the obstruction is generally permanent and may worsen over time. New advances in stem cell research have resulted in innovative stem cell treatments for those suffering from COPD. Stem cell therapy may help improve complications in patients with COPD and help those patients who have been unresponsive to traditional COPD drug treatments.
Stem cells harvested from the patient have the potential to replace and regenerate infected cells including lung tissue. These stem cells may then heal the body by replacing disease plagued cells, regenerating new cells, and suppressing the immune system’s macrophage response which engulfs and digests dying lung cells.
This application of regenerative medicine and stem cell therapy offers hope to patients battling degenerative diseases and has been shown to improve the quality of life for those living with COPD. Improvement may be seen in each of the following symptoms: reduction of dyspnea (difficult or labored breathing), increased energy, improved ability to walk alone, increased ability to perform daily tasks, reduction of reliance on supplemental oxygen, improved sleep, and enhanced mood.
After the patient’s stem cells are extracted and concentrated into a high yield of PRP, they may be administered in one of two ways: intravenously (injected directly into the vein) or via stem cell nebulization (a process by which stem cells are broken down into a nebulized state and then inhaled directly to target the lungs).